Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Nestle buys UK-based CM&D Pharma


      Swiss food giant Nestle has acquired CM&D Pharma, a UK-based drug maker that specialises in the development of products tailored for patients with Kidney Disease, for an undisclosed amount.

      Nestle through its subsidiary Nestle Health Science has completed the acquisition of CM&D Pharma, the Swiss firm said in a statement without disclosing the financial details.

      The acquisition of CM&D comes just a month after Nestle Health Science became operational.

      CM&D, a small company started in 2007 by former Sinclair Pharma PLC executive Danilo Massari, focuses on the research and development, and marketing and sales of foods for special medical purposes.

      The company's leading product Fostrap -- medical food in the form of a chewing gum for kidney patients -- is currently at late stage trials.

      "This acquisition is an excellent fit with Nestle Health Sciences strategic goal of being a pioneer in the promising area of science-based nutrition. We share CM&D's commitment to use health science for improving the quality of people's lives, and this acquisition will help to reinforce our position in this opportunity.

      "Additionally, CM&D will benefit from Nestle Health Science's commitment to biomedical research, and the resources of the Nestle Institute of Health Sciences," said Luis Cantarell, President and CEO at Nestle Health Science.

      Nestle Health Science is made up of the medical-nutrition business that the Swiss foods giant acquired from Novartis AG for USD 2.5 billion in 2007.

      Nestle, which has annual sales of more than USD 100 billion, had been an investor in CM&D through Inventages before buying it.

      According to industry experts, targeted health products as the next big thing for the food industry, mainly in developed markets like the US and the UK, with aging populations and rising medical costs.

      Feb 08, 2011


      Share this Article!

    Back to top^